|
Match
|
Document |
Document Title |
|
|
US20140121191 |
Oral Energy Supplement and Related Methods
The present invention relates to oral dosage formulations consisting of at least one active ingredient contained in a plurality of hydrophobic carriers dispersed in an aqueous medium comprising a... |
|
|
US20130123228 |
PROMOTING AXON REGENERATION IN THE ADULT CNS THROUGH CONTROL OF PROTEIN TRANSLATION
Survival of, or axon regeneration in a lesioned mature central nervous system (CNS) neuron is promoted by (a) contacting the neuron with a therapeutically effective amount of an exogenous... |
|
|
US20100331819 |
Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy
This invention relates to photodynamic therapy (PDT), more specifically PDT for atherosclerotic plaque via delivering PDT-loaded nanoparticles such as liposomes, polymersomes, micelles and... |
|
|
US20100310660 |
DRY POWDER MICROPARTICLES FOR PULMONARY DELIVERY
The invention provides a dry powder microparticle for pulmonary delivery, which comprises at least one nanoparticle in the form of liposome or micelle wherein the nanopaparticle encapsulates one... |
|
|
US20110236508 |
L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION
A formulation comprising large quantities of l-arginine and/or fat plaque dissolving agents which is palatable, stench free, and does not evoke nausea. The formulation is adapted to facilitate the... |
|
|
US20120282297 |
METHOD FOR TREATING CONSTIPATION
The invention relates to methods and compositions for the treatment of constipation. The method of the invention involves administration of a suppository containing chlorophyll, chlorophyllin... |
|
|
US20110105452 |
Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance
The present invention relates, in one embodiment, to a method of preventing or treating diabetes using low molecular weight antioxidants. In a further embodiment, the invention relates to a method... |
|
|
US20120289492 |
METHODS OF TREATING MITOCHONDRIAL DISORDERS USING METALLOPORPHYRINS
Methods of treating a mitochondrial disorder including epilepsy, a neurological disorder, an inherited mitochondrial disease or inherited epilepsies, a pediatric epilepsy, an encephalopathy or a... |
|
|
US20110243854 |
Methods and systems for identifying modulators of longevity
Methods of treating disorders such as neurofibromatosis-1 are provided, including methods in which catalytic antioxidants such as metalloporphyrins are administered. Methods of regulating... |
|
|
US20120065181 |
METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS
Described herein are methods of treating ischemic injury comprising administering to a subject in need thereof a therapeutically effective amount of a substituted porphyrin compound. Also... |
|
|
US20050085454 |
Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
A composition for the treatment, prevention or management of a condition in primates, especially humans comprising a phenolic antioxidant-chromium complex. |
|
|
US20140371192 |
ALPHA-FORM ZINC-PHTHALOCYANINE NANOWIRES HAVING ENHANCED WATER SOLUBILITY AND WATER DISPERSIBILITY, COMPOSITE OF AN ALPHA-FORM ZINC-PHTHALOCYANINE NANOWIRE/PHENOTHIAZINE, AND METHOD FOR PREPARING SAME
The present invention relates to alpha-form zinc-phthalocyanine nanowires (ZnPc NWs) having enhanced water solubility and water dispersibility, to a composite of an alpha-form zinc-phthalocyanine... |
|
|
US20130012443 |
METHODS OF TREATMENT OF CENTRAL NERVOUS SYSTEM HEMORRHAGE USING PROTOPORPHYRIN IX-FE COMPOUNDS
Described herein are methods and compositions relating to treatment of tissue damage resulting from a central nervous system (CNS) hemorrhage with a protoporphyrin IX-Fe compound. |
|
|
US20140093517 |
OXIDIZED LDL AS A BIOMARKER FOR NEUROLOGICAL COMPLICATIONS OF PREGNANCY
Methods for diagnosing and treating conditions associated with life-threatening neurological complications are provided. The methods involve in some aspects the identification of oxLDL and LOX-1... |
|
|
US20140378427 |
CABAZITAXEL-PLATINUM NANOPARTICLES AND METHODS OF USING SAME
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum compound having a heterocycle ligand.... |
|
|
US20100316628 |
AGENTS AND METHODS FOR TREATING RESPIRATORY DISORDERS
The present invention relates to a novel method of preventing and/or treating respiratory disorders and respiratory-related complications in a subject by inhibiting the release of nitric oxide... |
|
|
US20140343028 |
METHODS OF TREATING ORAL MUCOSITIS
Methods and kits for treating oral mucositis are disclosed. The treatment comprises administering to a patient in need thereof a Reactive Oxygen Species scavenger in a pharmaceutically acceptable... |
|
|
US20130225545 |
PORPHYRIN TREATMENT OF NEURODEGENERATIVE DISEASES
Compositions and methods of treating a neurodegenerative disorder are disclosed herein. |
|
|
US20150023914 |
USE OF TELLURIUM COMPOUNDS FOR THE TREATMENT ACTINIC KERATOSIS
Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a... |
|
|
US20110046100 |
Texaphyrin solutions and pharmaceutical formulations
A packaging system is described for a drug that provides protection from contamination, crystallization and/or degradation of the drug during storage of the system prior to its use. The packaging... |
|
|
US20150216875 |
MODULATING THE PRODUCTION OF NEURONS AND/OR OLIGODENDROCYTES FROM WHITE MATTER PROGENITOR CELLS
The present invention relates to a method of modulating production of neurons and/or oligodendrocytes from neural progenitor cells of human white matter and to a method of treating a subject for a... |
|
|
US20140073619 |
METHOD FOR TREATING CHRONIC PAIN
The present invention provides analgesic compounds comprising at least one modified metalloporphyrin compound. Also provided are methods of treating pain by orally administering an analgesic... |
|
|
US20150231150 |
SUBSTITUTED PORPHYRINS
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20140011794 |
SUBSTITUTED PORPHYRINS
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20120214780 |
SUBSTITUTED PORPHYRINS
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20110065679 |
Substituted Porphyrins
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20130084275 |
Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling
The present invention relates generally to methods and compositions for reducing Interleukin-4 or Interleukin-13 signaling, in particular to treat asthma and atopic dermatitis. The inventors have... |
|
|
US20110165065 |
MEANS FOR THE DETECTION AND TREATMENT OF PROSTATE CELLS
The present invention relates to a composition for the detection and the treatment of prostate cells and to methods for the diagnostic and therapeutic treatment of a human being using the... |
|
|
US20050244466 |
Photodynamic therapy in conjunction with intraocular implants
A method for treating an ocular condition is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory component and a bioerodible... |
|
|
US20140335025 |
TARGETING CORROLES FOR TUMOR TOXICITY AND MRI
Disclosed herein are compositions comprising a targeted corrole nanoparticle; and an acceptable excipient. Also disclosed are compositions comprising a targeted corrole nanoparticle; and an... |
|
|
US20140364406 |
Method Of Treating Or Preventing Pathologic Effects Of Acute Increases In Hyperglycemia And/Or Acute Increases Of Free Fatty Acid Flux
One aspect of the present invention relates to a method of treating or preventing pathologic sequelae of acute hyperglycemia and/or increased fatty acid flux in a subject. This method involves... |
|
|
US20120329767 |
Methods and Compositions for Treating Cancer
The present invention relates to uses or methods for treating proliferative diseases, in particular cancer, implementing ruthenium compounds, as well as to composition containing same. |
|
|
US20120264725 |
SUBSTITUTED PORPHYRINS
Substituted metalloporphyrin compounds are described, along with pharmaceutical compositions containing the same, and methods of use thereof in protecting cells from oxidant-induced toxicity and... |
|
|
US20150216923 |
Biochemical Scaffolds for Modulating Cell Function
A biochemical scaffold for regulating mammalian cell function, including a bioenergetic platform and a vibrational platform, the bioenergetic platform comprising a Krebs cycle modulator,... |
|
|
US20130237511 |
Copper Ion Delivery Platform for Pharmaceutical Agents
Methods for utilizing copper ions to bind to and help transport medicinal agents that contain a nitrogen atom or atoms are disclosed. The copper ion or ions serve as a delivery platform for a... |
|
|
US20050244500 |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
A method for treating a posterior ocular condition so as to improve vision is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory... |
|
|
US20080085881 |
Stop-and-go oxaliplatin treatment regimens
Methods of treating an oxaliplatin-sensitive cancer are disclosed in which a therapy comprising oxaliplatin is initiated, continued until a predetermined endpoint, stopped, then reintroduced after... |
|
|
US20140308309 |
COMPOSITION COMPRISING CHLORELLA EXTRACT FOR PREVENTING OR TREATING LIVER DISEASE
The present invention relates to a composition comprising chlorella extract for preventing or treating liver diseases. The composition comprising the chlorella extract according to the present... |
|
|
US20150224202 |
FORMULATIONS AND USES FOR MICROPARTICLE DELIVERY OF ZINC PROTOPORPHYRINS
Formulations and methods of use thereof that relate to biocompatible delivery of zinc protoporphyrin (ZnPP) are provided. In some embodiments, the ZnPP is formulated for oral delivery.... |
|
|
US20060217291 |
Radiosensitizer
There is provided a radiosensitizer containing an iron compound, more specifically, a radiosensitizer containing an iron compound selected from an inorganoiron compound, such as iron chloride,... |
|
|
US20070293467 |
Demethyl-Cantharidin Platinum Complex Isomers and Their Use
The present invention provides a stereo-isomer of the demethylcantharidin platinum complex of formula I and use thereof. The stereo-isomer inhibits the growth of cisplatin, carboplatin or... |
|
|
US20150125550 |
APPLICATION OF 2,9-DI-SEC-BUTYL-1,10-PHENANTHROLINE AS A GLIOBLASTOMA TUMOR CHEMOTHERAPY
A method of inhibiting cancer cell growth is provided. In some versions, the method includes exposing lung cancer cells or glioma cells to 2,9-di-sec-butyl-1,10-phenanthroline (SBP) or derivatives... |
|
|
US20150246057 |
Metalloporphyrin Neurological Treatments
Methods and compositions for treating a subject suffering from exposure to a chemical threat agent are disclosed. |
|
|
US20070060557 |
Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
Methods for preventing and treating damage to the optic nerve and/or retina by the use of SOD mimics, particularly pentaazacycle Mn(II) complex SOD mimics, are disclosed. |
|
|
US20070196428 |
Nitric oxide generating medical devices
Medical devices having a catalyst capable of catalyzing the generation of nitric oxide attached to the medical device and methods of treating a vascular condition using the devices are provided. |
|
|
US20120039800 |
Platinum Acridine Anti-Cancer Compounds And Methods Thereof
Acridine containing cisplatin compounds are disclosed that show greater efficacy against cancer than other cisplatin compounds. |
|
|
US20130071495 |
INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR USE IN THERAPEUTIC METHODS AND SCREENING METHOD RELATING THERETO
The present invention relates to an inhibitor of glycogen synthase kinase 3 (GSK-3) for use in a method of treating or preventing emphysema, a method of activating an emphysema cell, an activated... |
|
|
US20090099150 |
Methotrexate Combinations For Treating Inflammatory Diseases
Compounds, methods and kits for treating inflammatory diseases are disclosed. The treatment comprises administering to a patient in need thereof, methotrexate and a Reactive Oxygen Species... |
|
|
US20110184333 |
PHOTOLABILE CAGED TRANSITION METAL COMPLEXES AND METHODS OF USING THE SAME
The present invention provides compounds of Formula I: (I) along with compositions comprising the same and methods of using the same, such as for photodynamic therapy in the treatment of cancer. |
|
|
US20050026867 |
Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
Herein is disclosed a composition, comprising a superoxide dismutase mimic (SODm) associated with hyaluronic acid (HA), wherein the composition is a liquid at about 37° C. The composition is... |